Eli Lilly and Company's US$3bn manufacturing site in the Netherlands is set to create around 1,500 construction jobs during ...

In a bid to boost oral medicine manufacturing capacity in Europe for patients worldwide, Lilly has confirmed plans to invest ...

Indianapolis-based Eli Lilly and Company announced Monday, Nov. 3 that it plans to build a new $3 billion manufacturing ...

The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio ...

The new $3 billion manufacturing facility will be sited at the Leiden Bio Science Park in Katwijk, and will be Lilly's first ...

Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...

Increased our 2025 full-year revenue guidance to be in the range of $63.0 billion to $63.5 billion; reported EPS guidance raised to be in the range of $21.80 to $22.50 and non-GAAP EPS guidance raised ...

Lilly, an Indianapolis-based drugmaker, plans to build a $3 billion manufacturing plant in the Netherlands to boost ...

The Portland Foundation will hold an open house from 3 to 5 p.m. Thursday, Nov. 6, at John Jay Center for Learning, 101 S. Meridian St., Portland, to celebrate executive director Doug Inman’s 30 years ...

Eli Lilly and Company announced Wednesday, Oct. 29 a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico.

Along with the company’s investment plans in Puerto Rico, Lilly also announced plans to build a $5 billon manufacturing plant in Goochland County, Virgina, a $1 billion investment in its India-based ...

Lilly said the plant will strengthen its global supply chain and expand the capacity for its growing portfolio of oral ...